Jefferies Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,500
| Closed | -$9.88M | – | 1727 |
|
|
2021
Q3 | $9.88M | Buy |
+26,500
| New | +$10.1M | 0.07% | 260 |
|
|
2021
Q1 | – | Sell |
-8,000
| Closed | -$2.57M | – | 1724 |
|
|
2020
Q4 | $2.57M | Sell |
8,000
-33,700
| -81% | -$10.3M | 0.02% | 626 |
|
|
2020
Q3 | $11.2M | Buy |
41,700
+39,700
| +1,985% | +$10.7M | 0.12% | 128 |
|
|
2020
Q2 | $526 | Sell |
2,000
-15,900
| -89% | -$4.24M | 0.01% | 905 |
|
|
2020
Q1 | $4.13M | Buy |
17,900
+3,000
| +20% | +$818K | 0.05% | 384 |
|
|
2019
Q4 | $4.5M | Buy |
14,900
+6,600
| +80% | +$1.82M | 0.03% | 566 |
|
|
2019
Q3 | $1.99M | Sell |
8,300
-91,700
| -92% | -$25.1M | 0.02% | 1082 |
|
|
2019
Q2 | $28.2M | Buy |
100,000
+69,500
| +228% | +$19M | 0.21% | 65 |
|
|
2019
Q1 | $8.75M | Buy |
30,500
+21,200
| +228% | +$6.13M | 0.07% | 243 |
|
|
2018
Q4 | $2.44M | Buy |
9,300
+1,600
| +21% | +$440K | 0.02% | 726 |
|
|
2018
Q3 | $2.11M | Sell |
7,700
-11,600
| -60% | -$3.01M | 0.01% | 951 |
|
|
2018
Q2 | $4.59M | Buy |
19,300
+16,300
| +543% | +$3.77M | 0.03% | 531 |
|
|
2018
Q1 | $659K | Buy |
+3,000
| New | +$705K | ﹤0.01% | 1371 |
|
|
2017
Q4 | – | Sell |
-400
| Closed | -$76K | – | 2556 |
|
|
2017
Q3 | $76K | Sell |
400
-4,900
| -92% | -$933K | ﹤0.01% | 2182 |
|
|
2017
Q2 | $997K | Sell |
5,300
-200
| -4% | -$35.9K | 0.01% | 1306 |
|
|
2017
Q1 | $910K | Sell |
5,500
-42,900
| -89% | -$6.82M | 0.01% | 1325 |
|
|
2016
Q4 | $6.96M | Buy |
48,400
+47,400
| +4,740% | +$6.35M | 0.04% | 449 |
|
|
2016
Q3 | $125K | Sell |
1,000
-25,000
| -96% | -$3.23M | ﹤0.01% | 2012 |
|
|
2016
Q2 | $3.42M | Buy |
26,000
+6,200
| +31% | +$848K | 0.02% | 657 |
|
|
2016
Q1 | $2.75M | Sell |
19,800
-25,500
| -56% | -$3.41M | 0.02% | 708 |
|
|
2015
Q4 | $6.32M | Hold |
45,300
| – | – | 0.04% | 371 |
|
|
2015
Q3 | $6.34M | Buy |
45,300
+7,100
| +19% | +$1.07M | 0.04% | 400 |
|
|
2015
Q2 | $6.27M | Buy |
38,200
+29,300
| +329% | +$4.68M | 0.03% | 423 |
|
|
2015
Q1 | $1.37M | Sell |
8,900
-112,700
| -93% | -$16M | 0.01% | 912 |
|
|
2014
Q4 | $15.3M | Sell |
121,600
-103,600
| -46% | -$12.8M | 0.09% | 192 |
|
|
2014
Q3 | $26.9M | Buy |
+225,200
| New | +$25.8M | 0.18% | 101 |
|
|
2013
Q3 | – | Sell |
-1,000
| Closed | -$82K | – | 1990 |
|
|
2013
Q2 | $82K | Buy |
+1,000
| New | +$74.8K | ﹤0.01% | 1664 |
|
Other funds holding ELV
Jefferies Group's ELV Position: Q2 2022 in Review
Jefferies Group sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 1,000 shares — an estimated $491K sold.
Jefferies Group first reported a position in ELV in Q2 2013 and held it in 35 quarters. The position peaked at $20.6M in Q3 2021. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.
- Jefferies Group reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
- Jefferies Group sold 1,000 Elevance Health shares in Q2 2022, an estimated $491K.
- Jefferies Group first reported a position in Elevance Health in Q2 2013 and held it in 35 quarters.
- Jefferies Group's Elevance Health position peaked at $20.6M in Q3 2021.
- 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.
Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.